David McIntosh Shares: Egypt Achieves Self-Sufficiency in Plasma-Derived Medicines Thanks to Grifols
David McIntosh, Founder and Chair of United Plasma Action, posted on LinkedIn:
“Excellent News for Egyptian Patients AND a guiding light for other nations!!
I feel sure that fellow LinkedIners with a keen interest in blood, plasma and derived life-saving medicines will have found this news as exciting as Egyptian patients did:
Read the paper here.
While the fully appropriate treatment of all patients and currently undiagnosed sufferers, across all Low and Middle Income Countries, is still a long way off, progress in Egypt must surely give hope to millions way beyond that country’s borders.
The speed of progress has been immensely impressive, immediately starting to save lives after years of unsuccessful struggling against chronic national shortages of vital plasma-derived medicines.
The key ingredients?? –
a) The successful implementation of a positive public/private partnership
and
b) The introduction of plasmapheresis collection using the time-honoured method of Voluntary Reasonably Compensated Donation (VRCD)
Thus Egypt joins Germany, Austria, Hungary and Czechia in successfully adopting the American approach to plasma collection that has served those countries so well for so many years.
A hearty cheer for patient-centred, caring, common sense!!!
Hopefully, the backwoodsmen in Europe will finally sit up and take notice. Those who still advocate for uncompensated plasma donation and allow themselves to stay reliant on US imports to treat their patients properly must surely wake up to reality some time soon ….”
Read more from David McIntosh on Hemostasis Today.
-
Feb 20, 2026, 17:35Wolfgang Miesbach: Plasma FIX Is Only Part of the Story In Haemophilia B
-
Feb 20, 2026, 17:27Sheharyar Raza: Examining Guideline Discordance in Evidence-Based Apheresis Recommendations
-
Feb 20, 2026, 17:23Barbara Mora: Newly Discovered EPO Gene Intronic Variant as a Cause of Congenital Erythrocytosis
-
Feb 20, 2026, 16:48Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola
-
Feb 20, 2026, 16:41Uche Kennedy: Hemophilia Care Needs Systems Reform, Not Short-Term Fixes
-
Feb 20, 2026, 16:33Sonal Sonu: Real Clinical Maturity is Knowing When to Stop
-
Feb 20, 2026, 16:27Clear Recommendations for Daily Management and Family Support in Hemophilia A – WFH
-
Feb 20, 2026, 15:56Alan Nurden: Highlighting the Role of Activated Platelets in Heart and Kidney Complications of Diabetes
-
Feb 20, 2026, 15:51Domenico Girelli: Continuing Commitment to Rare Disease Research